Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

Medicine & Life Sciences

• human VEGFA protein 100%
• Vascular Endothelial Growth Factor A 61%
• Nitric Oxide 57%
• Endothelial Cells 52%
• Human Umbilical Vein Endothelial Cells 25%
• Protein-Tyrosine Kinases 10%
• Calcium Chelating Agents 8%
• Phosphoinositide-3 Kinase Inhibitors 8%
• arginine methyl ester 7%
• Nitric Oxide Synthase Type III 6%
• Phosphatidylinositol 3-Kinase 5%
• Phosphatidylinositol 3-Kinases 5%
• Nitric Oxide Synthase 5%
• Tyrosine 5%
• In Vitro Techniques 5%
• Gels 4%
• Collagen 4%
• Proteins 4%
• Calcium 4%
• Growth 2%